Skip to content
Screener

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$6.89B+70.6%
CVS Health logo
CVS HealthCVS
$11.54B-4.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Alignment Healthcare logo
Alignment HealthcareALHC
$707.71M+57.9%
Astrana Health logo
Astrana HealthASTH
$478.38M+85.0%
Agilon Health logo
Agilon HealthAGL
$178.81M+4.3%

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.45B+113%
P/S1.1×+0.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Clover Health Investments’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 8:06 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001801170-26-000122
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Cash flows from financing activities:
Issuance of common stock, net of early exercise liability30215
Cash paid for shares withheld related to stock-based compensation(7,893)(13,659)
Repurchases of common stock(18,297)
Net cash used in financing activities(7,863)(31,741)
Net increase (decrease) in cash and cash equivalents94,964(39,104)
Cash and cash equivalents, beginning of period78,301194,543
Cash and cash equivalents, end of period$173,265$155,439

Item 1. Financial Statements (Unaudited)

FAQ

What is Clover Health Investments's cash & equivalents?
Clover Health Investments (CLOV) reported cash & equivalents of $173.27M in Q1 2026.
How has Clover Health Investments's cash & equivalents changed year-over-year?
Clover Health Investments's cash & equivalents increased by 11.5% year-over-year, from $155.44M to $173.27M.
What is the long-term trend for Clover Health Investments's cash & equivalents?
Over 5 years (2020 to 2025), Clover Health Investments's cash & equivalents has grown at a -3.2% compound annual growth rate (CAGR), from $92.35M to $78.3M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Clover Health Investments's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude